ScholarWorks@Gyeongsang National University: Browsing ScholarWorks

Browsing by Jung, H. A.Author

Showing results 1 to 3 of 3

SCIESCOPUS

Erlotinib plus bevacizumab in patients with metastatic solid tumors with EGFR amplification: Results from the KOSMOS-II (KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced solid tumors, KCSG AL 22-09)

Lee, J. W.; Lee, Y-g.; Lee, G-w.; Jung, H. A.; Kim, K-p.; Kim, T-y.; Ryu, H.; Ryu, M. H.; Ahn, M. S.; Yun, H., et al.

ArticleIssue Date2024CitationAnnals of Oncology, v.35, pp S1580 - S1580PublisherOxford University Press

SCIESCOPUS

Exploratory biomarker analysis in EGFR mutated NSCLC patients who treated with atezolizumab plus bevacizumab and chemotherapy from phase III ATTLAS trial

Kim, H.; Park, S.; Kim, T. M.; Han, J-Y.; Lee, G-W.; Shim, B. Y.; Lee, Y-G.; Kim, S-W.; Ock, C-Y.; Hwang, S., et al.

ArticleIssue Date2024CitationAnnals of Oncology, v.35, pp S1636 - S1636PublisherOxford University Press

SCIESCOPUS

Final clinical outcomes of nationwide precision oncology pilot study; KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS) KCSG AL-20-05 open access

Kim, T-Y.; Kim, S. Y.; Kim, J. H.; Jung, H. A.; Choi, Y. J.; Hwang, I. G.; Cha, Y.; Lee, G-W.; Lee, Y-G.; Kim, T. M., et al.

ArticleIssue Date2023CitationAnnals of Oncology, v.34, pp S490 - S491PublisherOxford University Press

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Browsing by Jung, H. A.Author

BROWSE